Back

Paroxysmal versus persistent atrial fibrillation: predictive benefit from 10 seconds of surface 12-lead electrocardiogram

26 August 2018 (12:21 - 12:30)
Organised by:
Congress Presentation Part of: Atrial fibrillation - Detection, treatment, outcomes Defining Types of Atrial Fibrillation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Sungsoo Kim

Yonsei University, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Premature atrial contractions are associated with atrial fibrillation, brain ischemia, and mortality: a systematic review and meta-analysis
Doctor J. Himmelreich (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
The effect of non-recommended dosing of non-vitamin K antagonist oral anticoagulants (NOACs) on 1-year mortality in patients with newly diagnosed AF? Results from the GARFIELD-AF registry
Professor J. Camm (London, GB)
Abstract Slides Video
Presentation thumbnail
Real-world observational data confirm the efficacy of atrial antitachycardia pacing in terminating slow and regular atrial tachyarrhythmias in patients wearing implantable cardiac electronic devices.
Professor G. Boriani (Modena, IT)
Abstract
Presentation thumbnail
Value of interatrial block for the prediction of silent ischemic brain lesions
Doctor G. Cinier (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Prevalence of silent vascular brain lesions among patients with atrial fibrillation and no known history of stroke
Doctor S. Blum (Basel, CH)
Abstract

Access the full session

Session thumbnail
Atrial fibrillation - Detection, treatment, outcomes

The Event

Event poster

ESC Congress 2018

26 August 2018 12:21 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
Basic science and arrhythmia pathophysiology
thumbnail
Congress Session
How to manage atrial fibrillation in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources